Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001515852 | SCV001724013 | benign | Brugada syndrome | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003987552 | SCV002721452 | likely benign | not specified | 2022-02-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987552 | SCV004803602 | benign | not specified | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004716511 | SCV005300418 | benign | not provided | criteria provided, single submitter | not provided |